Matthaios Katsaras
Overview
Explore the profile of Matthaios Katsaras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karampitsakos T, Galaris A, Chrysikos S, Papaioannou O, Vamvakaris I, Barbayianni I, et al.
Respir Res
. 2023 Nov;
24(1):279.
PMID: 37964265
Background: Mediastinal lymph node enlargement is prevalent in patients with idiopathic pulmonary fibrosis (IPF). Studies investigating whether this phenomenon reflects specific immunologic activation are lacking. Methods: Programmed cell death-1 (PD-1)/...
2.
Karampitsakos T, Sotiropoulou V, Katsaras M, Tzouvelekis A
BMJ Case Rep
. 2023 Sep;
16(9).
PMID: 37758659
Psoriasis is an immune-mediated inflammatory disorder of the skin, characterised by uncontrolled proliferation and dysfunctional differentiation of keratinocytes. In our case series, pirfenidone was administered for the management of fibrotic...
3.
Karampitsakos T, Sotiropoulou V, Katsaras M, Tsiri P, Georgakopoulou V, Papanikolaou I, et al.
Front Med (Lausanne)
. 2023 May;
10:1194925.
PMID: 37122328
[This corrects the article DOI: 10.3389/fmed.2022.1083264.].
4.
Karampitsakos T, Sotiropoulou V, Katsaras M, Tsiri P, Georgakopoulou V, Papanikolaou I, et al.
Front Med (Lausanne)
. 2023 Feb;
9:1083264.
PMID: 36733935
Introduction: Post-acute sequelae of COVID-19 seem to be an emerging global crisis. Machine learning radiographic models have great potential for meticulous evaluation of post-COVID-19 interstitial lung disease (ILD). Methods: In...
5.
Karampitsakos T, Tzilas V, Papaioannou O, Chrysikos S, Vasarmidi E, Juge P, et al.
Front Med (Lausanne)
. 2023 Jan;
9:1096203.
PMID: 36698813
Introduction: Myositis associated interstitial lung disease (ILD) seems to be an under-recognized entity. Methods: In this multicenter, retrospective study, we recorded between 9/12/2019 and 30/9/2021 consecutive patients who presented in...
6.
Karampitsakos T, Papaioannou O, Tsiri P, Katsaras M, Katsimpris A, Kalogeropoulos A, et al.
Clin Microbiol Infect
. 2022 Oct;
29(3):372-378.
PMID: 36273769
Objective: Randomized controlled trials comparing tocilizumab and baricitinib in patients with coronavirus disease 2019 (COVID-19) are needed. This was an open-label, randomized controlled trial aiming to address this unmet need....
7.
Karampitsakos T, Papaioannou O, Dimeas I, Tsiri P, Sotiropoulou V, Tomos I, et al.
ERJ Open Res
. 2022 May;
8(2).
PMID: 35509438
https://bit.ly/3K2KXQ0.
8.
Sampsonas F, Karamouzos V, Karampitsakos T, Papaioannou O, Katsaras M, Lagadinou M, et al.
Front Med (Lausanne)
. 2022 Mar;
9:815799.
PMID: 35280891
Introduction: High-flow nasal cannula (HFNC) oxygenation method has been proven to be successful in oxygenation of patients with respiratory failure and has exhibited clinical superiority compared to low-flow nasal cannula...
9.
Karampitsakos T, Malakounidou E, Papaioannou O, Dimakopoulou V, Zarkadi E, Katsaras M, et al.
Respir Res
. 2021 Dec;
22(1):317.
PMID: 34937570
Background: Data on the safety and efficacy profile of tocilizumab in patients with severe COVID-19 needs to be enriched. Methods: In this open label, prospective study, we evaluated clinical outcomes...
10.
Papaioannou O, Karampitsakos T, Katsaras M, Sampsonas F, Tzouvelekis A
Adv Respir Med
. 2021 Oct;
PMID: 34668182
Established treatment regimens for the autosomal dominant hyperimmunoglobulin E syndrome, denominated Job syndrome, are lacking. Thus, Job syndrome still exerts a dramatic impact on patients' quality of life. Our aim...